To access this element change to forms mode OFF
Grant Award View - GA30082
Pre-hospital anti-fibrinolytics for traumatic coagulopathy and...
GA ID:
GA30082
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$656,155.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Pre-hospital anti-fibrinolytics for traumatic coagulopathy and haemorrhage-2 (The PATCH2 Study)
Purpose:
The PATCH-2 trial is clinical trial of a drug known as tranexamic acid. This is a relatively inexpensive drug that is currently used in the hospital in patients undergoing cardiac surgery or in patients who have bleeding after delivery. The use of this drug in patients with severe trauma has not been tested in the pre-hospital setting. The PATCH-2 trial will test whether tranexamic acid given in the prehospital setting improves patient outcomes by decreasing the amount of bleeding after trauma.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1165275
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA, QLD, NT, TAS, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, NEW ZEALAND